Mouwasat Medical Services Company (4002.SR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Mouwasat Medical Services Company, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 16.22x | 26.36x | 34.00x | 34.87x | 30.06x | 26.13x |
| P/B Ratio | 3.53x | 4.77x | 6.82x | 7.15x | 6.67x | 6.05x |
| P/S Ratio | 4.14x | 5.91x | 8.26x | 8.95x | 8.11x | 6.75x |
| Profitability | ||||||
| Gross Margin | 40.6% | 44.8% | 47.9% | 47.1% | 46.4% | 47.0% |
| Operating Margin | 27.0% | 25.2% | 28.0% | 28.4% | 29.0% | 28.3% |
| Net Margin | 25.5% | 22.4% | 24.3% | 25.7% | 27.0% | 25.8% |
| EBITDA Margin | 34.6% | 33.8% | 36.9% | 36.9% | 36.4% | 35.5% |
| Liquidity | ||||||
| Current Ratio | 1.74x | 1.99x | 1.95x | 1.98x | 2.05x | 2.17x |
| Quick Ratio | 1.48x | 1.73x | 1.71x | 1.72x | 1.76x | 1.83x |
| Leverage | ||||||
| Debt/Equity | 0.26x | 0.21x | 0.24x | 0.31x | 0.32x | 0.34x |
YoY = year-over-year change. Source: FMP..